2024-10-19 - Analysis Report
## Thermo Fisher Scientific Inc. (TMO) Stock Analysis Report

**Company Overview:** Thermo Fisher Scientific Inc. is a leading provider of scientific instruments, consumables, and services for research, healthcare, and industrial markets. 

**1. Performance Analysis:**

* **Cumulative Return:** TMO has generated a cumulative return of 243.81%, significantly outperforming the S&P 500 (VOO) with a return of 137.88%.
* **Relative Performance:** The current relative performance of TMO against the S&P 500 stands at 105.93%, meaning it has outperformed the benchmark index by 105.93%. This places it in the 49.03rd percentile of its historical performance range, indicating a strong relative outperformance.

**2. Recent Price Movement:**

* **Closing Price:** 601.71
* **5-day Moving Average:** 599.36
* **20-day Moving Average:** 604.06
* **60-day Moving Average:** 607.44

The stock is trading slightly below its 20-day and 60-day moving averages, suggesting a potential short-term pullback.

**3. Technical Indicators:**

* **RSI:** 37.74 - Indicates a potential oversold condition, suggesting a possible rebound.
* **PPO:** -0.09 - Shows a negative momentum, hinting at a potential short-term weakness.
* **Delta_Previous_Relative_Divergence:** -5.95 - Negative value indicates a recent decline in the stock's relative performance.
* **Expected Return:** 13.39% - This represents a potential long-term outperformance of the S&P 500 if invested over a period of two years or more.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-02 | 4.05 | 10.54 B$ |
| 2024-05-03 | 3.47 | 10.35 B$ |
| 2023-11-03 | 4.44 | 10.57 B$ |
| 2023-08-04 | 3.53 | 10.69 B$ |
| 2024-08-02 | 3.53 | 10.69 B$ |

The latest earnings report (2024-08-02) showed an EPS of 4.05, exceeding analyst expectations. This indicates continued strong performance and potential for future growth.

**5. News and Recent Issues:**

* Recent market outlook for TMO remains positive, with analysts citing its strong market position, robust earnings growth, and potential for continued innovation.
* **FINBOLD:** The publication highlights Thermo Fisher's resilience and its ability to navigate industry challenges, resulting in strong financial performance. 
* **Analyst Opinions:** Most analysts maintain a "Buy" or "Strong Buy" rating on TMO, highlighting its long-term potential and consistent track record of success.

**6. Overall Analysis:**

TMO exhibits strong long-term performance, exceeding the S&P 500 considerably. Recent earnings and outlook suggest continued growth. While technical indicators signal potential short-term weakness, the overall positive sentiment and long-term growth potential make TMO an attractive investment option for long-term investors.

**7. Investment Recommendation:** 

TMO presents a compelling investment opportunity for long-term investors seeking exposure to the scientific instrumentation and life sciences sector. Its consistent performance, strong financial position, and future growth prospects make it a worthwhile addition to a well-diversified portfolio. However, it is important to consider potential short-term volatility and manage investment risk accordingly. 
